Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YTHDC1 | Q96MU7 | 2/20 | 0.33 |
| ▸ | CDK1 | P06493 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.31 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.30 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.30 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.30 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.30 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.30 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30424513 | 1.00 | YTHDC1 (0.33) | YTHDC1CDK1LCKKMT2AALK | |
| SCHEMBL30425567 | 0.86 | YTHDC1 (0.49) | YTHDC1CDK1 | |
| SCHEMBL29015694 | 0.86 | YTHDC1 (0.49) | YTHDC1CDK1 | |
| SCHEMBL30426111 | 0.79 | ALK (0.45) | ALK | |
| SCHEMBL27238032 | 0.79 | ALK (0.45) | ALK | |
| SCHEMBL29015706 | 0.78 | ALK (0.35) | LCKKMT2AALKPKM | |
| SCHEMBL30872014 | 0.78 | ALK (0.35) | LCKKMT2AALKPKM | |
| SCHEMBL30425415 | 0.78 | TNNI3K (0.35) | YTHDC1ALKTNNI3KPKM | |
| SCHEMBL29015755 | 0.78 | TNNI3K (0.35) | YTHDC1ALKTNNI3KPKM | |
| SCHEMBL30872003 | 0.78 | GLO1 (0.43) | KMT2AALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116249690-A | Indoline compounds and derivatives as EGFR inhibitors | 百济神州有限公司 | 2023-06-09 | — | — | CN | disclosed |